A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms
Interventions: DRUG: PF-06647020 Q3W|DRUG: fluconazole|DRUG: PF-06647020 Q2W|DRUG: PF-06647020 combined with Avelumab
Sponsor: Pfizer